Centene Co. ( NYSE:CNC – Get Free Report ) has been assigned an average rating of “Moderate Buy” from the fourteen ratings firms that are presently covering the company, MarketBeat.com reports.
One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $81.31.
CNC has been the topic of several analyst reports. Barclays increased their price target on Centene from $91.00 to $93.
00 and gave the company an “overweight” rating in a report on Friday. Robert W. Baird dropped their price objective on Centene from $83.
00 to $66.00 and set a “neutral” rating on the stock in a research note on Friday, October 25th. Truist Financial decreased their target price on Centene from $89.
00 to $84.00 and set a “buy” rating for the company in a research note on Friday. UBS Group raised Centene from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $79.
00 to $80.00 in a research report on Friday. Finally, Wells Fargo & Company reduced their price objective on Centene from $91.
00 to $90.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Get Our Latest Analysis on CNC Centene Stock Performance Insider Buying and Selling In related news, CEO Sarah London bought 4,117 shares of the company’s stock in a transaction dated Friday, November 8th.
The stock was acquired at an average cost of $60.80 per share, with a total value of $250,313.60.
Following the acquisition, the chief executive officer now owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.
62 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link . Also, CFO Andrew Lynn Asher purchased 17,200 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th.
The stock was bought at an average cost of $58.14 per share, for a total transaction of $1,000,008.00.
Following the purchase, the chief financial officer now owns 486,847 shares in the company, valued at $28,305,284.58. This represents a 3.
66 % increase in their ownership of the stock. The disclosure for this purchase can be found here . 0.
33% of the stock is owned by company insiders. Institutional Inflows and Outflows A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Park Place Capital Corp raised its stake in shares of Centene by 1,190.
0% in the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after acquiring an additional 357 shares during the last quarter. WR Wealth Planners LLC raised its position in Centene by 41.
4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after purchasing an additional 137 shares during the last quarter. Chris Bulman Inc acquired a new position in Centene in the second quarter worth $33,000.
Crewe Advisors LLC grew its holdings in shares of Centene by 174.3% during the second quarter. Crewe Advisors LLC now owns 683 shares of the company’s stock worth $45,000 after purchasing an additional 434 shares during the last quarter.
Finally, Private Trust Co. NA raised its holdings in shares of Centene by 75.3% in the third quarter.
Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after buying an additional 332 shares during the last quarter. 93.
63% of the stock is owned by institutional investors. About Centene ( Get Free Report Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments.
The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support. Read More Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter .
.
Business
Centene Co. (NYSE:CNC) Given Average Rating of “Moderate Buy” by Brokerages
Centene Co. (NYSE:CNC – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fourteen ratings firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and eight have assigned a buy recommendation to the [...]